Virax Biolabs Group Ltd.
13F holders, Q3 2025 (September 30)1holders
$0.62avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Virax Biolabs Group Ltd. in their 13F filings. The largest holder was Farther Finance Advisors, LLC ($13).
- Company
- Virax Biolabs Group Ltd.
- CUSIP
- G9495L109
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $13 |
| Exits | 0 | $0 |
Ownership 1 holders
| Farther Finance Advisors, LLC | 0.00% | New | 21 | $13 |
"% of holder's portfolio" is VIRAX BIOLABS GROUP LTD's weight in each manager's 13F, not the share of Virax Biolabs Group Ltd. the manager owns.